| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 TCF4 NANOGP8 NANOG PCLO ZMYND8 TACC2 MED1 CSRP3 CCNT2 PPARGC1A NCOR2 GTF2F1 KMT2A MYOCD BAIAP2 BSN TBX5 | 2.12e-06 | 753 | 131 | 18 | GO:0008134 |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.51e-05 | 8 | 131 | 3 | GO:0098882 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.70e-05 | 24 | 131 | 4 | GO:0008093 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 4.25e-05 | 30 | 131 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.85e-05 | 31 | 131 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 TCF4 NANOGP8 ANK3 MAP1A NANOG DTL GAS2 ZMYND8 TUT1 MED1 ZXDA GRIP1 PPARGC1A NCOR2 HSH2D MYOCD BAIAP2 USP15 ZNF541 | 6.76e-05 | 1160 | 131 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | tubulin binding | SPAST MAP7D3 MAP1A GAS2 DCX CEP350 PPARGC1A TTLL4 MAPRE2 MTUS2 NIN | 1.22e-04 | 428 | 131 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | 2.01e-04 | 308 | 131 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 2.54e-04 | 4 | 131 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.25e-04 | 140 | 131 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.37e-04 | 21 | 131 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | chromatin binding | TICRR TCF4 NANOGP8 NANOG E2F4 MED1 CCNT2 PPARGC1A NCOR2 KDM4D GTF2F1 KMT2A ANKRD17 ASXL2 | 3.59e-04 | 739 | 131 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.26e-04 | 206 | 131 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 TCF4 NANOGP8 ANK3 MAP1A NANOG DTL GAS2 ZMYND8 TUT1 MED1 ZXDA GRIP1 PPARGC1A NCOR2 HSH2D MYOCD BAIAP2 USP15 ZNF541 | 5.33e-04 | 1356 | 131 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TCF4 NANOGP8 SALL3 NANOG POU2F2 E2F4 ZNF217 GATA5 FOXN3 MED1 ZNF865 SOX13 FOXP4 HOXD1 ZNF544 ZNF335 TET1 ZFHX3 TBX5 | 6.32e-04 | 1271 | 131 | 19 | GO:0000987 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPAST MAP7D3 ANK3 MAP1A GAS2 RCSD1 DCX CSRP3 CRMP1 FARP2 CEP350 PPARGC1A TTLL4 MARK2 MAPRE2 MTUS2 NIN | 8.57e-04 | 1099 | 131 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TCF4 NANOGP8 SALL3 NANOG POU2F2 E2F4 ZNF217 GATA5 MED1 ZNF865 SOX13 FOXP4 HOXD1 ZNF544 ZNF335 TET1 ZFHX3 TBX5 | 1.28e-03 | 1244 | 131 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXM1 TCF4 NANOGP8 SALL3 NANOG POU2F2 E2F4 ZNF217 GATA5 MED1 ZNF865 SOX13 CREBRF FOXP4 HOXD1 ZNF544 ZNF335 TET1 ZFHX3 TBX5 | 1.32e-03 | 1459 | 131 | 20 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TRERF1 TCF4 ZMYND8 TACC2 MED1 CSRP3 PPARGC1A NCOR2 KMT2A MYOCD TBX5 | 1.59e-03 | 582 | 131 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 2.18e-03 | 83 | 131 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.63e-03 | 42 | 131 | 3 | GO:0098918 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXM1 TRERF1 TCF4 NANOGP8 RPS6KA5 NANOG PPP1R12A BTBD18 ZMYND8 POU2F2 E2F4 POGZ GATA5 MED1 CSRP3 CREBRF CCNT2 PPARGC1A GTF2F1 ZNF544 ZNF335 TET1 KMT2A ZFHX3 MYOCD ASXL2 IKBKB NOS1 TBX5 | 6.76e-09 | 1390 | 129 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCNL2 SPAST MAP7D3 ANK3 MAP1A PPP1R12A E2F4 TACC2 DCX CEP43 CEP350 LIMK2 TTLL4 CEP131 MARK2 MAPRE2 DYNC1LI2 NIN | 5.63e-07 | 720 | 129 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | CCNL2 SPAST MAP7D3 ANK3 MAP1A PPP1R12A E2F4 TACC2 DCX CEP43 CEP350 LIMK2 TTLL4 CEP131 MARK2 BSN MAPRE2 ARHGAP21 DYNC1LI2 NIN | 9.17e-06 | 1058 | 129 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | response to growth factor | GDF5 TCF4 NANOGP8 NANOG GATA5 MED1 ZYX EPN2 GRIP1 PPARGC1A TET1 KMT2A ZFHX3 MYOCD BAIAP2 USP15 NOS1 DYNC1LI2 | 9.84e-06 | 883 | 129 | 18 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 2.19e-05 | 54 | 129 | 5 | GO:0032968 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | GDF5 TCF4 NANOGP8 NANOG GATA5 MED1 ZYX EPN2 GRIP1 PPARGC1A TET1 KMT2A MYOCD BAIAP2 USP15 NOS1 DYNC1LI2 | 2.27e-05 | 850 | 129 | 17 | GO:0071363 |
| GeneOntologyBiologicalProcess | cell cycle process | FOXM1 CCNL2 TICRR NANOGP8 SPAST ANK3 PPP1R12A BTBD18 DTL TACC2 POGZ FOXN3 MED1 ZNF503 LIMK2 MKI67 ANKRD17 CEP131 MAPRE2 CCNI ZNF541 KNL1 NIN | 2.81e-05 | 1441 | 129 | 23 | GO:0022402 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 4.31e-05 | 62 | 129 | 5 | GO:0032786 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXM1 TRERF1 TCF4 NANOGP8 RPS6KA5 NANOG ZMYND8 ZNF217 GATA5 FOXN3 MED1 SOX13 ZNF503 CREBRF NCOR2 FOXP4 CBY1 TET1 ZFHX3 MYOCD ASXL2 ZNF541 | 5.37e-05 | 1399 | 129 | 22 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXM1 TRERF1 TCF4 NANOGP8 RPS6KA5 NANOG ZMYND8 ZNF217 GATA5 FOXN3 MED1 SOX13 ZNF503 CREBRF NCOR2 FOXP4 CBY1 TET1 ZFHX3 MYOCD ASXL2 ZNF541 | 6.23e-05 | 1413 | 129 | 22 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of cell communication by electrical coupling | 1.16e-04 | 3 | 129 | 2 | GO:0010650 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.16e-04 | 3 | 129 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD2 SYNRG SPAST RGPD8 ANK3 MAP1A AUP1 PPP1R12A HMGXB4 RCSD1 TACC2 NUP214 MED1 GRIP1 EPS15L1 IGHG1 CEP131 RIMS1 NUP188 BSN ARHGAP21 RGPD5 | 1.43e-04 | 1496 | 129 | 22 | GO:0046907 |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.48e-04 | 127 | 129 | 6 | GO:0006368 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 2.31e-04 | 4 | 129 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 2.31e-04 | 4 | 129 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.52e-04 | 20 | 129 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 2.93e-04 | 144 | 129 | 6 | GO:0006354 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 2.96e-04 | 93 | 129 | 5 | GO:0034243 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | FOXM1 CCNL2 TICRR NANOGP8 SPAST NANOG DTL GAS2 E2F4 NUP214 FOXN3 MED1 CCNT2 MKI67 ANKRD17 MYOCD CEP131 CCNI KNL1 | 3.01e-04 | 1256 | 129 | 19 | GO:0051726 |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 3.83e-04 | 5 | 129 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 3.83e-04 | 5 | 129 | 2 | GO:0042663 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 RGPD2 TCF4 RGPD8 HMGXB4 E2F4 TUT1 ZNF217 NUP214 MED1 CCNT2 NCOR2 GTF2F1 ZNF335 TET1 KMT2A FIP1L1 ACIN1 MYOCD ASXL2 NUP188 ZCCHC7 ZNF541 RGPD5 | 3.32e-06 | 1377 | 129 | 24 | GO:0140513 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.26e-05 | 8 | 129 | 3 | GO:0048788 | |
| GeneOntologyCellularComponent | chromatin | FOXM1 TCF4 NANOGP8 NANOG HMGXB4 ZMYND8 POU2F2 E2F4 POGZ GATA5 FOXN3 MED1 SOX13 PPARGC1A NCOR2 KDM4D FOXP4 HOXD1 TET1 ANKRD17 ZFHX3 MYOCD TBX5 | 3.46e-05 | 1480 | 129 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | microtubule organizing center | FAM184A SPAST PPP1R12A FBF1 DTL TACC2 CEP43 CRMP1 CEP350 LIMK2 CBY1 TTLL4 CEP131 MAPRE2 MTUS2 DYNC1LI2 NIN | 5.11e-05 | 919 | 129 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 7.95e-05 | 14 | 129 | 3 | GO:0099569 | |
| GeneOntologyCellularComponent | cell cortex region | 1.70e-04 | 45 | 129 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.83e-04 | 85 | 129 | 5 | GO:0000118 | |
| GeneOntologyCellularComponent | centrosome | FAM184A SPAST PPP1R12A FBF1 DTL TACC2 CEP43 CRMP1 CEP350 LIMK2 CEP131 MTUS2 DYNC1LI2 NIN | 2.92e-04 | 770 | 129 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | supramolecular fiber | SPAST ANK3 MAP1A PPP1R12A FBF1 GAS2 RCSD1 DCX CSRP3 GRIP1 TTLL4 BAIAP2 MARK2 MAPRE2 NOS1 MTUS2 DYNC1LI2 NIN | 3.37e-04 | 1179 | 129 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | SPAST ANK3 MAP1A PPP1R12A FBF1 GAS2 RCSD1 DCX CSRP3 GRIP1 TTLL4 BAIAP2 MARK2 MAPRE2 NOS1 MTUS2 DYNC1LI2 NIN | 3.65e-04 | 1187 | 129 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 3.71e-04 | 23 | 129 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | nuclear pore | 4.08e-04 | 101 | 129 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | centriole | 7.02e-04 | 172 | 129 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD2 SPAST RGPD8 DTL NUP214 ANKRD17 CEP131 NUP188 CCNI NOS1 RGPD5 | 7.12e-04 | 560 | 129 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | inhibitory synapse | 9.09e-04 | 31 | 129 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.03e-03 | 8 | 129 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.14e-03 | 74 | 129 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | SPAST MAP1A FBF1 GAS2 RCSD1 DCX GRIP1 TTLL4 BAIAP2 MARK2 MAPRE2 MTUS2 DYNC1LI2 NIN | 1.33e-03 | 899 | 129 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear membrane | 1.48e-03 | 349 | 129 | 8 | GO:0031965 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.65e-03 | 10 | 129 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.65e-03 | 10 | 129 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | microtubule | SPAST MAP1A DCX GRIP1 TTLL4 BAIAP2 MAPRE2 MTUS2 DYNC1LI2 NIN | 1.75e-03 | 533 | 129 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | CD40 receptor complex | 2.00e-03 | 11 | 129 | 2 | GO:0035631 | |
| GeneOntologyCellularComponent | transferase complex | CCNL2 RGPD2 TRAF3 RGPD8 DTL MED1 CCNT2 GTF2F1 FBXO10 PIK3C2B ZNF335 KMT2A IKBKB CCNI | 2.51e-03 | 963 | 129 | 14 | GO:1990234 |
| GeneOntologyCellularComponent | dendrite | ANK3 MAP1A PCLO ZMYND8 DCX CRMP1 GRIP1 PPARGC1A BAIAP2 MARK2 BSN NOS1 NIN | 2.51e-03 | 858 | 129 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ANK3 MAP1A PCLO ZMYND8 DCX CRMP1 GRIP1 PPARGC1A BAIAP2 MARK2 BSN NOS1 NIN | 2.56e-03 | 860 | 129 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | spindle | 2.62e-03 | 471 | 129 | 9 | GO:0005819 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.92e-03 | 157 | 129 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.28e-03 | 14 | 129 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear body | CCNL2 RAPH1 TUT1 ZNF217 CREBRF PPARGC1A NCOR2 CBY1 MKI67 ACIN1 ZFHX3 USP15 KNL1 | 3.88e-03 | 903 | 129 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | transcription regulator complex | 3.90e-03 | 596 | 129 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | protein kinase complex | 4.10e-03 | 170 | 129 | 5 | GO:1902911 | |
| Domain | Znf_piccolo | 4.66e-05 | 2 | 128 | 2 | IPR008899 | |
| Domain | zf-piccolo | 4.66e-05 | 2 | 128 | 2 | PF05715 | |
| Domain | Grip | 4.98e-05 | 11 | 128 | 3 | SM00755 | |
| Domain | GRIP | 4.98e-05 | 11 | 128 | 3 | PF01465 | |
| Domain | Ran_BP1 | 6.61e-05 | 12 | 128 | 3 | PF00638 | |
| Domain | RANBD1 | 6.61e-05 | 12 | 128 | 3 | PS50196 | |
| Domain | GRIP_dom | 6.61e-05 | 12 | 128 | 3 | IPR000237 | |
| Domain | GRIP | 6.61e-05 | 12 | 128 | 3 | PS50913 | |
| Domain | RanBD | 8.55e-05 | 13 | 128 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 8.55e-05 | 13 | 128 | 3 | IPR000156 | |
| Domain | Homeodomain-like | TRERF1 TCF4 NANOGP8 NANOG POU2F2 POGZ NCOR2 HOXD1 ZFHX3 ZNF541 | 9.78e-05 | 332 | 128 | 10 | IPR009057 |
| Domain | NUT | 4.60e-04 | 5 | 128 | 2 | IPR024310 | |
| Domain | NUT_N | 4.60e-04 | 5 | 128 | 2 | IPR024309 | |
| Domain | NUT | 4.60e-04 | 5 | 128 | 2 | PF12881 | |
| Domain | PDZ | 6.10e-04 | 151 | 128 | 6 | PS50106 | |
| Domain | PDZ | 6.31e-04 | 152 | 128 | 6 | IPR001478 | |
| Domain | SANT_dom | 7.28e-04 | 26 | 128 | 3 | IPR017884 | |
| Domain | SANT | 9.09e-04 | 28 | 128 | 3 | PS51293 | |
| Domain | CYCLINS | 9.09e-04 | 28 | 128 | 3 | PS00292 | |
| Domain | Rab_bind | 9.57e-04 | 7 | 128 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 9.57e-04 | 7 | 128 | 2 | IPR032023 | |
| Domain | Cyclin_L/T | 1.27e-03 | 8 | 128 | 2 | IPR015429 | |
| Domain | Cyclin_N | 1.48e-03 | 33 | 128 | 3 | PF00134 | |
| Domain | Cyclin_N | 1.48e-03 | 33 | 128 | 3 | IPR006671 | |
| Domain | Ubiquitin-rel_dom | 1.69e-03 | 184 | 128 | 6 | IPR029071 | |
| Domain | Myb_DNA-binding | 1.75e-03 | 35 | 128 | 3 | PF00249 | |
| Domain | - | 2.02e-03 | 10 | 128 | 2 | 1.10.220.60 | |
| Domain | CYCLIN | 2.23e-03 | 38 | 128 | 3 | SM00385 | |
| Domain | MYB_LIKE | 2.23e-03 | 38 | 128 | 3 | PS50090 | |
| Domain | ZF_CXXC | 2.46e-03 | 11 | 128 | 2 | PS51058 | |
| Domain | Znf_CXXC | 2.46e-03 | 11 | 128 | 2 | IPR002857 | |
| Domain | zf-CXXC | 2.46e-03 | 11 | 128 | 2 | PF02008 | |
| Domain | EH | 2.46e-03 | 11 | 128 | 2 | PS50031 | |
| Domain | EH | 2.46e-03 | 11 | 128 | 2 | SM00027 | |
| Domain | EH_dom | 2.46e-03 | 11 | 128 | 2 | IPR000261 | |
| Domain | - | 2.58e-03 | 40 | 128 | 3 | 1.10.472.10 | |
| Domain | PDZ | 2.88e-03 | 141 | 128 | 5 | PF00595 | |
| Domain | C8 | 2.94e-03 | 12 | 128 | 2 | PF08742 | |
| Domain | TIL | 2.94e-03 | 12 | 128 | 2 | PF01826 | |
| Domain | Cyclin-like | 3.18e-03 | 43 | 128 | 3 | IPR013763 | |
| Domain | Znf_FYVE_PHD | 3.44e-03 | 147 | 128 | 5 | IPR011011 | |
| Domain | ELM2_dom | 3.46e-03 | 13 | 128 | 2 | IPR000949 | |
| Domain | Unchr_dom_Cys-rich | 3.46e-03 | 13 | 128 | 2 | IPR014853 | |
| Domain | ELM2 | 3.46e-03 | 13 | 128 | 2 | PF01448 | |
| Domain | C8 | 3.46e-03 | 13 | 128 | 2 | SM00832 | |
| Domain | ELM2 | 3.46e-03 | 13 | 128 | 2 | PS51156 | |
| Domain | ELM2 | 3.46e-03 | 13 | 128 | 2 | SM01189 | |
| Domain | PDZ | 3.54e-03 | 148 | 128 | 5 | SM00228 | |
| Domain | Znf_C2H2 | TRERF1 SALL3 TUT1 ZNF217 POGZ ZNF865 ZXDA ZNF503 FOXP4 ZNF544 ZNF335 ZFHX3 ZNF541 | 3.55e-03 | 805 | 128 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | TRERF1 SALL3 TUT1 ZNF217 POGZ ZNF865 ZXDA ZNF503 FOXP4 ZNF544 ZNF335 ZFHX3 ZNF541 | 3.66e-03 | 808 | 128 | 13 | SM00355 |
| Domain | - | 3.75e-03 | 150 | 128 | 5 | 2.30.42.10 | |
| Domain | TF_fork_head_CS_2 | 3.85e-03 | 46 | 128 | 3 | IPR030456 | |
| Domain | TIL_dom | 4.02e-03 | 14 | 128 | 2 | IPR002919 | |
| Domain | MIT | 4.02e-03 | 14 | 128 | 2 | IPR007330 | |
| Domain | TF_fork_head_CS_1 | 4.09e-03 | 47 | 128 | 3 | IPR018122 | |
| Domain | FH | 4.60e-03 | 49 | 128 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.60e-03 | 49 | 128 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.60e-03 | 49 | 128 | 3 | PS00658 | |
| Domain | Fork_head_dom | 4.60e-03 | 49 | 128 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 4.60e-03 | 49 | 128 | 3 | PS50039 | |
| Domain | Forkhead | 4.60e-03 | 49 | 128 | 3 | PF00250 | |
| Domain | SANT | 4.87e-03 | 50 | 128 | 3 | SM00717 | |
| Domain | VWF_type-D | 5.25e-03 | 16 | 128 | 2 | IPR001846 | |
| Domain | VWFD | 5.25e-03 | 16 | 128 | 2 | PS51233 | |
| Domain | VWD | 5.25e-03 | 16 | 128 | 2 | SM00216 | |
| Domain | VWD | 5.25e-03 | 16 | 128 | 2 | PF00094 | |
| Domain | SANT/Myb | 5.44e-03 | 52 | 128 | 3 | IPR001005 | |
| Domain | CTCK_1 | 6.64e-03 | 18 | 128 | 2 | PS01185 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.67e-05 | 50 | 100 | 5 | MM14610 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 3.16e-05 | 26 | 100 | 4 | M2499 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.79e-04 | 40 | 100 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.97e-04 | 41 | 100 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.17e-04 | 42 | 100 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.38e-04 | 43 | 100 | 4 | MM14609 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG SPAST MAP7D3 RAPH1 PPP1R12A DTL RAB11FIP1 ZYX EPN2 C6orf132 CEP350 GRIP1 LIMK2 PIK3C2B TET1 OTUD7A KMT2A FIP1L1 ANKRD17 CEP131 USP54 BAIAP2 PEAK1 MARK2 ARHGAP21 | 1.97e-15 | 861 | 131 | 25 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 TRERF1 SYNRG RAPH1 RPS6KA5 ZMYND8 ZNF217 NUP214 POGZ MED1 ZYX CCNT2 NCOR2 EPS15L1 ZNF335 MKI67 KMT2A FIP1L1 ACIN1 ANKRD17 RIMS1 MARK2 DYNC1LI2 | 1.83e-14 | 774 | 131 | 23 | 15302935 |
| Pubmed | DTL TACC2 PLEKHA6 MED1 RAB11FIP1 ZXDA ZYX EPS15L1 GTF2F1 ZC2HC1A MKI67 FIP1L1 ACIN1 CEP131 MARK2 USP15 DYNC1LI2 | 8.34e-12 | 503 | 131 | 17 | 16964243 | |
| Pubmed | TRERF1 RGPD2 RGPD8 RAPH1 ZMYND8 ZNF217 NUP214 POGZ NCOR2 TET1 ANKRD17 ZFHX3 CEP131 ARHGAP21 KNL1 | 6.60e-11 | 418 | 131 | 15 | 34709266 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 DTL ZNF217 NUP214 POGZ SOX13 ZNF503 NCOR2 FOXP4 TET1 MKI67 KMT2A ZFHX3 ASXL2 | 7.42e-11 | 351 | 131 | 14 | 38297188 |
| Pubmed | FOXM1 TRERF1 TCF4 NANOGP8 SALL3 NANOG HMGXB4 ZMYND8 POU2F2 E2F4 POGZ SOX13 ZYX LIMK2 ZC2HC1A ACIN1 ZFHX3 TBX5 | 1.64e-09 | 808 | 131 | 18 | 20412781 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SYNRG RAPH1 POGZ PLEKHA6 RAB11FIP1 LRCH1 SOX13 CEP43 ZYX FARP2 CEP350 EPS15L1 GTF2F1 HROB ZC2HC1A PIK3C2B TTLL4 FIP1L1 CRYBG1 ARHGAP21 | 2.27e-09 | 1038 | 131 | 20 | 26673895 |
| Pubmed | SYNRG MAP7D3 ANK3 RAPH1 PPP1R12A POGZ MED1 ZYX EPS15L1 TET1 KMT2A ACIN1 PEAK1 USP15 RGPD5 | 2.77e-09 | 549 | 131 | 15 | 38280479 | |
| Pubmed | MAP1A RAPH1 PPP1R12A HMGXB4 ZMYND8 MED1 LRCH1 CEP43 CRMP1 CEP131 MAPRE2 ARHGAP21 DYNC1LI2 KNL1 | 3.42e-09 | 472 | 131 | 14 | 38943005 | |
| Pubmed | 6.67e-09 | 7 | 131 | 4 | 17704298 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | FOXM1 SYNRG RGPD8 MAP1A DTL TACC2 ZNF217 SOX13 NCOR2 GTF2F1 PIK3C2B CEP131 BSN KNL1 NIN | 6.95e-09 | 588 | 131 | 15 | 38580884 |
| Pubmed | CCNL2 MAP1A PPP1R12A FBF1 BTBD18 HMGXB4 ZMYND8 POGZ RAB11FIP1 NCOR2 FOXP4 LIMK2 UTP25 FIP1L1 ANKRD17 ZFHX3 NUP188 USP54 KNL1 NIN | 7.67e-09 | 1116 | 131 | 20 | 31753913 | |
| Pubmed | ANK3 PLEKHA6 RAB11FIP1 LRCH1 EPN2 FARP2 GRIP1 PIK3C2B CBY1 SLC39A6 PEAK1 MARK2 ARHGAP21 | 7.96e-09 | 421 | 131 | 13 | 36976175 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG MAP7D3 MAP1A RAPH1 PPP1R12A ZMYND8 TACC2 NUP214 MED1 ZYX EPS15L1 MKI67 KMT2A ACIN1 ANKRD17 MAPRE2 ARHGAP21 KNL1 | 1.54e-08 | 934 | 131 | 18 | 33916271 |
| Pubmed | RGPD8 DTL NUP214 ZNF503 FARP2 CEP350 GTF2F1 TTLL4 FIP1L1 CEP131 USP54 BAIAP2 MAPRE2 USP15 DYNC1LI2 KNL1 | 1.89e-08 | 733 | 131 | 16 | 34672954 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD2 RGPD8 MAP1A PCLO PLEKHA6 EPS15L1 RIMS1 PEAK1 MARK2 BSN | 1.97e-08 | 231 | 131 | 10 | 16452087 |
| Pubmed | FOXM1 MAP7D3 PPP1R12A MED1 CEP43 ZYX ZNF503 CEP350 EPS15L1 GTF2F1 KMT2A FIP1L1 CEP131 USP15 NIN | 2.36e-08 | 645 | 131 | 15 | 25281560 | |
| Pubmed | TRERF1 RGPD2 TRAF3 RGPD8 ANK3 PPP1R12A DCX CRMP1 NCOR2 EPS15L1 ZC2HC1A ANKRD17 CEP131 RIMS1 BAIAP2 BSN NOS1 ARHGAP21 | 2.46e-08 | 963 | 131 | 18 | 28671696 | |
| Pubmed | TICRR SALL3 ANK3 PPP1R12A DTL TACC2 DCX CRMP1 PPARGC1A TTLL4 TET1 ACIN1 ANKRD17 CRYBG1 ASXL2 NUP188 PEAK1 ARHGAP21 DYNC1LI2 | 2.68e-08 | 1084 | 131 | 19 | 11544199 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ANK3 RAPH1 NUP214 PLEKHA6 ZYX EPN2 C6orf132 EPS15L1 CRYBG1 BAIAP2 PEAK1 MARK2 USP15 ARHGAP21 | 3.27e-08 | 565 | 131 | 14 | 25468996 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXM1 TRERF1 TCF4 NANOG POU2F2 E2F4 GATA5 FOXN3 SOX13 CREBRF FOXP4 HOXD1 ZNF335 KMT2A ZFHX3 ZNF541 TBX5 | 6.07e-08 | 908 | 131 | 17 | 19274049 |
| Pubmed | FOXM1 NANOGP8 NANOG HMGXB4 POU2F2 FOXN3 SOX13 ZYX FOXP4 ZFHX3 | 6.66e-08 | 263 | 131 | 10 | 20932939 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD2 RGPD8 PPP1R12A DTL TACC2 NUP214 POGZ CEP43 CEP350 EPS15L1 GTF2F1 MKI67 CEP131 ASXL2 NUP188 MARK2 DYNC1LI2 KNL1 RGPD5 | 7.25e-08 | 1155 | 131 | 19 | 20360068 |
| Pubmed | FOXM1 TCF4 ZMYND8 POU2F2 TACC2 TUT1 ZNF217 POGZ FOXN3 SOX13 ZYX FOXP4 MKI67 KMT2A ZFHX3 | 8.10e-08 | 709 | 131 | 15 | 22988430 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | CCNL2 TCF4 TRAF3 TACC2 EPN2 CREBRF NCOR2 TTLL4 TET1 ZFHX3 PEAK1 MARK2 REV1 | 1.33e-07 | 536 | 131 | 13 | 15840001 |
| Pubmed | 1.34e-07 | 103 | 131 | 7 | 32744500 | ||
| Pubmed | CCNL2 TCF4 TRAF3 TACC2 EPN2 CREBRF NCOR2 TTLL4 TET1 ZFHX3 PEAK1 MARK2 REV1 | 1.39e-07 | 538 | 131 | 13 | 10512203 | |
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 33058869 | ||
| Pubmed | 2.10e-07 | 226 | 131 | 9 | 31452512 | ||
| Pubmed | RGPD2 SYNRG SPAST RGPD8 ANK3 MAP1A PCLO TACC2 EPS15L1 SLC39A6 CEP131 RIMS1 BAIAP2 PEAK1 BSN MAPRE2 USP15 NOS1 | 2.98e-07 | 1139 | 131 | 18 | 36417873 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CCNL2 RPS6KA5 AUP1 PPP1R12A ZYX CCNT2 NCOR2 LIMK2 UTP25 KMT2A NUP188 MARK2 IKBKB CCNI ARHGAP21 KNL1 | 3.55e-07 | 910 | 131 | 16 | 36736316 |
| Pubmed | TRERF1 TCF4 TRAF3 HMGXB4 ZMYND8 ZNF217 NUP214 POGZ SOX13 ZNF503 NCOR2 FOXP4 MKI67 KMT2A FIP1L1 ANKRD17 ZFHX3 CEP131 ASXL2 USP54 | 4.21e-07 | 1429 | 131 | 20 | 35140242 | |
| Pubmed | ANK3 MAP1A PPP1R12A PCLO PLEKHA6 CRMP1 EPN2 EPS15L1 ZC2HC1A IGHG1 KMT2A RIMS1 USP54 BAIAP2 PEAK1 MARK2 BSN NOS1 ARHGAP21 MTUS2 | 4.31e-07 | 1431 | 131 | 20 | 37142655 | |
| Pubmed | Foxm1 controls a pro-stemness microRNA network in neural stem cells. | 5.19e-07 | 5 | 131 | 3 | 29476172 | |
| Pubmed | Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. | 5.19e-07 | 5 | 131 | 3 | 20622153 | |
| Pubmed | Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker. | 5.19e-07 | 5 | 131 | 3 | 31582397 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SALL3 MAP7D3 HMGXB4 ZMYND8 NUP214 POGZ MED1 PRAM1 NCOR2 EPS15L1 MKI67 KMT2A FIP1L1 ACIN1 ZCCHC7 KNL1 | 6.61e-07 | 954 | 131 | 16 | 36373674 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG FAM184A MAP7D3 RAPH1 CEP350 GRIP1 EPS15L1 HROB ZC2HC1A USP54 BAIAP2 USP15 ARHGAP21 DYNC1LI2 NIN | 8.44e-07 | 853 | 131 | 15 | 28718761 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 8.49e-07 | 135 | 131 | 7 | 31077711 | |
| Pubmed | MAP1A PCLO PLEKHA6 EPN2 EPS15L1 RIMS1 BAIAP2 MARK2 BSN DYNC1LI2 | 8.52e-07 | 347 | 131 | 10 | 17114649 | |
| Pubmed | FAM184A AUP1 PPP1R12A HMGXB4 ZMYND8 ZNF217 MED1 RAB11FIP1 EPN2 C6orf132 FARP2 GTF2F1 UTP25 KMT2A ANKRD17 CRYBG1 ZFHX3 CEP131 BAIAP2 MARK2 | 8.68e-07 | 1497 | 131 | 20 | 31527615 | |
| Pubmed | TRERF1 SPAST ZMYND8 ZNF217 POGZ MED1 ZYX ZNF503 CCNT2 PRAM1 NCOR2 GTF2F1 MKI67 KMT2A FIP1L1 ASXL2 KNL1 | 9.22e-07 | 1103 | 131 | 17 | 34189442 | |
| Pubmed | 1.04e-06 | 6 | 131 | 3 | 19812333 | ||
| Pubmed | Nanog, Oct4 and Tet1 interplay in establishing pluripotency. | 1.04e-06 | 6 | 131 | 3 | 27146218 | |
| Pubmed | 1.04e-06 | 6 | 131 | 3 | 14734538 | ||
| Pubmed | 1.09e-06 | 21 | 131 | 4 | 19596656 | ||
| Pubmed | 1.37e-06 | 209 | 131 | 8 | 36779422 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.44e-06 | 146 | 131 | 7 | 23892456 | |
| Pubmed | MAP7D3 ANK3 AUP1 ZNF865 CEP350 EPS15L1 MKI67 FIP1L1 ZFHX3 CEP131 BAIAP2 PEAK1 ARHGAP21 DYNC1LI2 | 1.51e-06 | 777 | 131 | 14 | 35844135 | |
| Pubmed | Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation. | 1.81e-06 | 7 | 131 | 3 | 31130414 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.81e-06 | 7 | 131 | 3 | 15710750 | |
| Pubmed | Identification of Oct4-activating compounds that enhance reprogramming efficiency. | 1.81e-06 | 7 | 131 | 3 | 23213213 | |
| Pubmed | Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation. | 1.81e-06 | 7 | 131 | 3 | 29997176 | |
| Pubmed | ANK3 RAPH1 RAB11FIP1 ZYX CEP350 NCOR2 GTF2F1 MKI67 SLC39A6 CEP131 BAIAP2 PEAK1 MAPRE2 KNL1 PHLPP2 NIN | 2.26e-06 | 1049 | 131 | 16 | 27880917 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 2.41e-06 | 101 | 131 | 6 | 24613305 | |
| Pubmed | ANK3 MAP1A RPS6KA5 NUP214 POGZ PLEKHA6 ZYX CEP350 RGL1 ANKRD17 BAIAP2 | 2.49e-06 | 486 | 131 | 11 | 20936779 | |
| Pubmed | ANK3 AUP1 ZMYND8 SOX13 ZYX EPN2 GRIP1 NCOR2 LIMK2 ASXL2 ZCCHC7 KNL1 | 2.63e-06 | 591 | 131 | 12 | 15231748 | |
| Pubmed | 2.88e-06 | 8 | 131 | 3 | 26199412 | ||
| Pubmed | 2.88e-06 | 8 | 131 | 3 | 23178929 | ||
| Pubmed | 3.07e-06 | 233 | 131 | 8 | 29518331 | ||
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 3.15e-06 | 27 | 131 | 4 | 23395962 | |
| Pubmed | MAP7D3 AUP1 MED1 EPN2 FARP2 NCOR2 EPS15L1 PIK3C2B BAIAP2 IKBKB USP15 MTUS2 | 3.28e-06 | 604 | 131 | 12 | 38803224 | |
| Pubmed | Rebalancing gene haploinsufficiency in vivo by targeting chromatin. | 3.67e-06 | 28 | 131 | 4 | 27256596 | |
| Pubmed | 3.80e-06 | 169 | 131 | 7 | 31462741 | ||
| Pubmed | XPO5 promotes primary miRNA processing independently of RanGTP. | 4.24e-06 | 29 | 131 | 4 | 32296071 | |
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 38237590 | ||
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 21144999 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXM1 TCF4 MAP7D3 PPP1R12A HMGXB4 ZMYND8 POU2F2 POGZ FOXN3 NCOR2 FOXP4 FIP1L1 ANKRD17 ASXL2 | 4.67e-06 | 857 | 131 | 14 | 25609649 |
| Pubmed | 5.38e-06 | 116 | 131 | 6 | 30804394 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 5.62e-06 | 67 | 131 | 5 | 16987237 | |
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 33246328 | ||
| Pubmed | Ectopic expression of GATA6 bypasses requirement for Grb2 in primitive endoderm formation. | 6.15e-06 | 10 | 131 | 3 | 20925113 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 6.15e-06 | 10 | 131 | 3 | 30595551 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 6.65e-06 | 184 | 131 | 7 | 32908313 | |
| Pubmed | 7.46e-06 | 263 | 131 | 8 | 34702444 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 8.43e-06 | 11 | 131 | 3 | 15681609 | |
| Pubmed | Role of FOXC1 in regulating APSCs self-renewal via STI-1/PrPC signaling. | 8.43e-06 | 11 | 131 | 3 | 31588228 | |
| Pubmed | 8.59e-06 | 73 | 131 | 5 | 22094256 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | SYNRG ANK3 MAP1A RAPH1 DCX GRIP1 ZC2HC1A SLC39A6 RIMS1 MARK2 MAPRE2 | 9.21e-06 | 558 | 131 | 11 | 35063084 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | MAP7D3 RAPH1 PPP1R12A MKI67 FIP1L1 ACIN1 PEAK1 ARHGAP21 KNL1 | 9.85e-06 | 361 | 131 | 9 | 30344098 |
| Pubmed | RAPH1 PPP1R12A NUP214 LRCH1 ZYX FARP2 CCNT2 EPS15L1 KMT2A FIP1L1 PEAK1 MAPRE2 USP15 ARHGAP21 | 9.91e-06 | 916 | 131 | 14 | 32203420 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MAP7D3 ANK3 PPP1R12A E2F4 MED1 RAB11FIP1 CEP43 ZYX EPN2 EPS15L1 CBY1 CEP131 BAIAP2 MARK2 MAPRE2 USP15 DYNC1LI2 | 1.01e-05 | 1321 | 131 | 17 | 27173435 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.04e-05 | 130 | 131 | 6 | 35545047 | |
| Pubmed | 1.12e-05 | 77 | 131 | 5 | 21525287 | ||
| Pubmed | 1.12e-05 | 12 | 131 | 3 | 23684982 | ||
| Pubmed | 1.15e-05 | 37 | 131 | 4 | 24335282 | ||
| Pubmed | 1.18e-05 | 201 | 131 | 7 | 23535732 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.23e-05 | 134 | 131 | 6 | 25452129 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.28e-05 | 38 | 131 | 4 | 12791264 | |
| Pubmed | Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. | 1.41e-05 | 2 | 131 | 2 | 23100278 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 12124344 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 1.41e-05 | 2 | 131 | 2 | 23403927 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 1.41e-05 | 2 | 131 | 2 | 26793095 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 20332206 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 1.41e-05 | 2 | 131 | 2 | 21935939 | |
| Pubmed | Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). | 1.41e-05 | 2 | 131 | 2 | 12618768 | |
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 1.41e-05 | 2 | 131 | 2 | 19415763 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 29678764 | ||
| Pubmed | Antagonistic effects of doublecortin and MARK2/Par-1 in the developing cerebral cortex. | 1.41e-05 | 2 | 131 | 2 | 19036994 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 27895715 | ||
| Interaction | YWHAG interactions | SYNRG TICRR TRAF3 SPAST MAP7D3 RAPH1 PPP1R12A DTL RAB11FIP1 EPN2 C6orf132 FARP2 CEP350 GRIP1 PIK3C2B IGHG1 CBY1 TET1 OTUD7A KMT2A FIP1L1 ACIN1 ANKRD17 CEP131 USP54 BAIAP2 PEAK1 MARK2 ARHGAP21 | 1.20e-09 | 1248 | 130 | 29 | int:YWHAG |
| Interaction | YWHAH interactions | SYNRG TICRR SPAST MAP7D3 PPP1R12A DTL MED1 RAB11FIP1 EPN2 C6orf132 CEP350 GRIP1 SNCAIP PIK3C2B CBY1 TET1 OTUD7A KMT2A ANKRD17 CEP131 RIMS1 USP54 BAIAP2 PEAK1 MARK2 ARHGAP21 NIN | 1.61e-09 | 1102 | 130 | 27 | int:YWHAH |
| Interaction | SFN interactions | SYNRG MAP7D3 MAP1A PPP1R12A DTL RAB11FIP1 C6orf132 CEP350 GRIP1 PIK3C2B CBY1 KMT2A ANKRD17 CEP131 USP54 BAIAP2 PEAK1 ZCCHC7 MARK2 MAPRE2 ARHGAP21 | 3.44e-09 | 692 | 130 | 21 | int:SFN |
| Interaction | YWHAQ interactions | SYNRG TICRR MAP7D3 PPP1R12A DTL TUT1 MED1 RAB11FIP1 EPN2 C6orf132 CEP350 GRIP1 PIK3C2B IGHG1 CBY1 TET1 OTUD7A KMT2A ANKRD17 CEP131 USP54 BAIAP2 PEAK1 ZCCHC7 MARK2 ARHGAP21 | 1.00e-08 | 1118 | 130 | 26 | int:YWHAQ |
| Interaction | YWHAZ interactions | SYNRG TICRR MAP7D3 RAPH1 RPS6KA5 PPP1R12A DTL TACC2 RAB11FIP1 LRCH1 EPN2 C6orf132 GRIP1 PIK3C2B IGHG1 CBY1 KMT2A ANKRD17 CEP131 ASXL2 USP54 BAIAP2 PEAK1 ZCCHC7 MARK2 NOS1 ARHGAP21 NIN | 1.76e-08 | 1319 | 130 | 28 | int:YWHAZ |
| Interaction | NUP43 interactions | SPAST RGPD8 PPP1R12A ZMYND8 MUC19 E2F4 NUP214 POGZ CCNT2 NCOR2 MKI67 KMT2A ACIN1 ZFHX3 ASXL2 BAIAP2 ZCCHC7 KNL1 RGPD5 | 2.03e-08 | 625 | 130 | 19 | int:NUP43 |
| Interaction | YWHAE interactions | SYNRG TICRR MAP7D3 PPP1R12A DTL TACC2 RAB11FIP1 LRCH1 DCX ZYX C6orf132 GRIP1 NCOR2 PIK3C2B IGHG1 CBY1 TET1 KMT2A ANKRD17 CEP131 ASXL2 USP54 BAIAP2 PEAK1 MARK2 ARHGAP21 NIN | 2.57e-08 | 1256 | 130 | 27 | int:YWHAE |
| Interaction | MAPRE3 interactions | MAP7D3 MAP1A TACC2 CEP43 C6orf132 CEP350 HROB ZC2HC1A CEP131 MARK2 MAPRE2 ARHGAP21 | 3.23e-08 | 230 | 130 | 12 | int:MAPRE3 |
| Interaction | KDM1A interactions | TRERF1 TCF4 RAPH1 NANOG LINC02875 PPP1R12A ZMYND8 E2F4 ZNF217 NUP214 POGZ CEP350 NCOR2 TET1 ANKRD17 ZFHX3 CEP131 BAIAP2 USP15 ARHGAP21 KNL1 TBX5 NIN | 3.30e-08 | 941 | 130 | 23 | int:KDM1A |
| Interaction | YWHAB interactions | SYNRG TICRR MAP7D3 PPP1R12A DTL RAB11FIP1 ZYX EPN2 C6orf132 CEP350 GRIP1 PIK3C2B CBY1 KMT2A ANKRD17 CEP131 USP54 BAIAP2 PEAK1 ZCCHC7 MARK2 IKBKB ARHGAP21 | 1.27e-07 | 1014 | 130 | 23 | int:YWHAB |
| Interaction | PPIA interactions | TCF4 SALL3 ANK3 MAP1A RAPH1 PPP1R12A HMGXB4 ZMYND8 E2F4 MED1 LRCH1 CEP43 CRMP1 MKI67 CEP131 ASXL2 MAPRE2 USP15 ARHGAP21 DYNC1LI2 KNL1 | 2.44e-07 | 888 | 130 | 21 | int:PPIA |
| Interaction | RCOR1 interactions | TCF4 RAPH1 PPP1R12A ZMYND8 ZNF217 NCOR2 TET1 MKI67 ANKRD17 ZFHX3 CEP131 USP15 ARHGAP21 KNL1 TBX5 | 7.16e-07 | 494 | 130 | 15 | int:RCOR1 |
| Interaction | MAPRE1 interactions | MAP7D3 RAPH1 PPP1R12A TACC2 NUP214 CEP43 CEP350 ZC2HC1A CEP131 MAPRE2 ARHGAP21 MTUS2 DYNC1LI2 RGPD5 NIN | 1.18e-06 | 514 | 130 | 15 | int:MAPRE1 |
| Interaction | AR interactions | TRERF1 TCF4 ZMYND8 POU2F2 E2F4 ZNF217 MED1 RAB11FIP1 GRIP1 NCOR2 KDM4D FOXP4 GTF2F1 KMT2A ACIN1 HSH2D ZFHX3 CEP131 NUP188 USP54 KNL1 | 1.47e-06 | 992 | 130 | 21 | int:AR |
| Interaction | CDH1 interactions | ANK3 RAPH1 NUP214 PLEKHA6 ZYX EPN2 C6orf132 FARP2 EPS15L1 ZC2HC1A AJAP1 MKI67 CRYBG1 BAIAP2 PEAK1 MARK2 USP15 ARHGAP21 | 2.20e-06 | 768 | 130 | 18 | int:CDH1 |
| Interaction | NXF2 interactions | 3.88e-06 | 65 | 130 | 6 | int:NXF2 | |
| Interaction | CEP120 interactions | 5.67e-06 | 106 | 130 | 7 | int:CEP120 | |
| Interaction | DCAF15 interactions | FOXM1 MAP1A PPP1R12A DTL RCSD1 ZYX ZNF503 EPS15L1 USP54 USP15 | 6.21e-06 | 255 | 130 | 10 | int:DCAF15 |
| Interaction | FEV interactions | 6.88e-06 | 203 | 130 | 9 | int:FEV | |
| Interaction | MED4 interactions | FAM184A MAP7D3 MED1 CEP43 ZYX CEP350 EPS15L1 GTF2F1 FIP1L1 CEP131 USP15 RGPD5 NIN | 7.06e-06 | 450 | 130 | 13 | int:MED4 |
| Interaction | GSK3A interactions | FOXM1 SYNRG MAP7D3 MAP1A CEP43 CEP350 ACIN1 CRYBG1 CEP131 PEAK1 MARK2 ARHGAP21 NIN | 9.79e-06 | 464 | 130 | 13 | int:GSK3A |
| Interaction | CFAP184 interactions | 1.04e-05 | 162 | 130 | 8 | int:CFAP184 | |
| Interaction | AFDN interactions | SPAST CBY1 OTUD7A KMT2A CEP131 USP54 PEAK1 MARK2 ARHGAP21 MTUS2 NIN | 1.07e-05 | 333 | 130 | 11 | int:AFDN |
| Interaction | CEP135 interactions | MAP7D3 FBF1 CEP43 CEP350 GRIP1 PIK3C2B CEP131 USP54 ARHGAP21 NIN | 1.09e-05 | 272 | 130 | 10 | int:CEP135 |
| Interaction | ZMYND10 interactions | 1.11e-05 | 22 | 130 | 4 | int:ZMYND10 | |
| Interaction | SOX2 interactions | TRERF1 SALL3 MAP1A NANOG PPP1R12A ZMYND8 TUT1 ZNF217 NUP214 POGZ MED1 NCOR2 FOXP4 ZC2HC1A KMT2A FIP1L1 ANKRD17 ZFHX3 MARK2 USP15 NOS1 ARHGAP21 KNL1 NIN | 1.22e-05 | 1422 | 130 | 24 | int:SOX2 |
| Interaction | CAMSAP2 interactions | 1.41e-05 | 169 | 130 | 8 | int:CAMSAP2 | |
| Interaction | EGR2 interactions | 1.54e-05 | 171 | 130 | 8 | int:EGR2 | |
| Interaction | VASP interactions | SYNRG MAP1A RAPH1 CEP43 ZYX C6orf132 CEP350 BAIAP2 PEAK1 ARHGAP21 | 2.14e-05 | 294 | 130 | 10 | int:VASP |
| Interaction | CEP63 interactions | 2.14e-05 | 179 | 130 | 8 | int:CEP63 | |
| Interaction | MIB1 interactions | FAM184A RGPD8 MAP7D3 E2F4 CEP43 EPS15L1 PIK3C2B CEP131 USP15 NIN | 2.20e-05 | 295 | 130 | 10 | int:MIB1 |
| Interaction | CTNNB1 interactions | FOXM1 TCF4 ANK3 NANOG PPP1R12A NUP214 GATA5 PLEKHA6 DCX GRIP1 AJAP1 CBY1 MKI67 KMT2A ASXL2 USP54 IKBKB USP15 ARHGAP21 | 2.55e-05 | 1009 | 130 | 19 | int:CTNNB1 |
| Interaction | CDC16 interactions | 3.17e-05 | 246 | 130 | 9 | int:CDC16 | |
| Interaction | CREBBP interactions | FOXM1 TRERF1 TRAF3 RPS6KA5 HMGXB4 TACC2 GRIP1 PPARGC1A NCOR2 GTF2F1 KMT2A ZCCHC7 MARK2 IKBKB | 3.32e-05 | 599 | 130 | 14 | int:CREBBP |
| Interaction | SPICE1 interactions | 3.41e-05 | 191 | 130 | 8 | int:SPICE1 | |
| Interaction | TRIM36 interactions | 4.17e-05 | 144 | 130 | 7 | int:TRIM36 | |
| Interaction | NCOA6 interactions | 4.36e-05 | 145 | 130 | 7 | int:NCOA6 | |
| Interaction | FBXO38 interactions | 4.36e-05 | 145 | 130 | 7 | int:FBXO38 | |
| Interaction | ITSN1 interactions | RPS6KA5 NUP214 ZYX EPN2 EPS15L1 PIK3C2B OTUD7A MTUS2 DYNC1LI2 | 4.74e-05 | 259 | 130 | 9 | int:ITSN1 |
| Interaction | ANK3 interactions | 4.89e-05 | 201 | 130 | 8 | int:ANK3 | |
| Interaction | BAIAP2 interactions | 4.89e-05 | 201 | 130 | 8 | int:BAIAP2 | |
| Interaction | NAA40 interactions | SYNRG MAP7D3 MAP1A RAPH1 PPP1R12A ZMYND8 TACC2 NUP214 MED1 ZYX EPS15L1 MKI67 KMT2A ACIN1 ANKRD17 MAPRE2 ARHGAP21 KNL1 | 5.72e-05 | 978 | 130 | 18 | int:NAA40 |
| Interaction | CDK6 interactions | 7.85e-05 | 215 | 130 | 8 | int:CDK6 | |
| Interaction | EGLN3 interactions | TICRR TCF4 MAP7D3 AUP1 LRCH1 FARP2 CEP350 NCOR2 HROB ZC2HC1A TTLL4 ANKRD17 NUP188 USP54 PEAK1 IKBKB MAPRE2 USP15 ARHGAP21 KNL1 NIN | 8.27e-05 | 1296 | 130 | 21 | int:EGLN3 |
| Interaction | PPP1CC interactions | TRAF3 MAP7D3 RAPH1 PPP1R12A TACC2 RAB11FIP1 KDM4D SNCAIP MKI67 FIP1L1 ACIN1 ASXL2 PEAK1 ARHGAP21 KNL1 | 8.42e-05 | 738 | 130 | 15 | int:PPP1CC |
| Interaction | SOX5 interactions | 8.79e-05 | 162 | 130 | 7 | int:SOX5 | |
| Interaction | HDAC1 interactions | TRERF1 CCNL2 RAPH1 NANOG ZMYND8 E2F4 ZNF217 NUP214 GRIP1 NCOR2 TET1 MKI67 KMT2A ANKRD17 ZFHX3 CEP131 USP15 ARHGAP21 KNL1 | 8.98e-05 | 1108 | 130 | 19 | int:HDAC1 |
| Interaction | TBR1 interactions | 9.22e-05 | 113 | 130 | 6 | int:TBR1 | |
| Interaction | WWTR1 interactions | SYNRG ANK3 RAPH1 PPP1R12A POGZ ZYX EPS15L1 KMT2A PEAK1 USP15 RGPD5 | 9.30e-05 | 422 | 130 | 11 | int:WWTR1 |
| Interaction | BICD2 interactions | RGPD8 RAPH1 DCX HROB ZC2HC1A USP54 BAIAP2 USP15 DYNC1LI2 RGPD5 NIN | 1.01e-04 | 426 | 130 | 11 | int:BICD2 |
| Interaction | RAB3IP interactions | 1.02e-04 | 115 | 130 | 6 | int:RAB3IP | |
| Interaction | POU5F1 interactions | TCF4 SALL3 NANOG ZNF217 ZNF865 PRAM1 NCOR2 FOXP4 TET1 ACIN1 ANKRD17 ZFHX3 USP15 | 1.05e-04 | 584 | 130 | 13 | int:POU5F1 |
| Interaction | NIN interactions | FAM184A MAP7D3 CEP43 CEP350 CEP131 USP54 BAIAP2 ARHGAP21 DYNC1LI2 NIN | 1.14e-04 | 359 | 130 | 10 | int:NIN |
| Interaction | PFN1 interactions | SYNRG MAP1A RAPH1 PCLO CRMP1 C6orf132 CEP350 CEP131 BAIAP2 PEAK1 ARHGAP21 ZNF541 | 1.15e-04 | 509 | 130 | 12 | int:PFN1 |
| Interaction | PLK1 interactions | FOXM1 ANK3 PPP1R12A FBF1 MED1 CEP43 FARP2 EPS15L1 IKBKB USP15 TBX5 NIN | 1.17e-04 | 510 | 130 | 12 | int:PLK1 |
| Interaction | SAMD4B interactions | 1.41e-04 | 122 | 130 | 6 | int:SAMD4B | |
| Interaction | TLX1 interactions | 1.42e-04 | 175 | 130 | 7 | int:TLX1 | |
| Interaction | FABP4 interactions | 1.53e-04 | 42 | 130 | 4 | int:FABP4 | |
| Interaction | CEP152 interactions | 1.64e-04 | 179 | 130 | 7 | int:CEP152 | |
| Interaction | TLE3 interactions | 1.66e-04 | 376 | 130 | 10 | int:TLE3 | |
| Interaction | RGS14 interactions | 1.68e-04 | 240 | 130 | 8 | int:RGS14 | |
| Interaction | DYNLT1 interactions | 1.73e-04 | 241 | 130 | 8 | int:DYNLT1 | |
| Interaction | NR3C1 interactions | MAP7D3 RPS6KA5 AUP1 FBF1 POU2F2 NUP214 POGZ MED1 CEP43 CEP350 GRIP1 PPARGC1A NCOR2 ANKRD17 NUP188 BSN KNL1 | 1.77e-04 | 974 | 130 | 17 | int:NR3C1 |
| Interaction | TNIK interactions | ANK3 DCX CEP43 NCOR2 RIMS1 BAIAP2 IKBKB NOS1 ARHGAP21 DYNC1LI2 | 1.85e-04 | 381 | 130 | 10 | int:TNIK |
| Interaction | TRAF3IP3 interactions | 2.12e-04 | 84 | 130 | 5 | int:TRAF3IP3 | |
| Interaction | SIRT6 interactions | RGPD8 NUP214 MED1 ZNF865 UTP25 MKI67 FIP1L1 ANKRD17 CEP131 NUP188 USP54 USP15 RGPD5 | 2.14e-04 | 628 | 130 | 13 | int:SIRT6 |
| Interaction | CEP170 interactions | 2.24e-04 | 318 | 130 | 9 | int:CEP170 | |
| Interaction | EPHA2 interactions | ANK3 PLEKHA6 RAB11FIP1 LRCH1 EPN2 FARP2 GRIP1 PIK3C2B CBY1 SLC39A6 USP54 PEAK1 MARK2 ARHGAP21 | 2.29e-04 | 719 | 130 | 14 | int:EPHA2 |
| Interaction | LYN interactions | CCNL2 ANK3 DTL RAB11FIP1 CEP43 FARP2 PRAM1 SLC39A6 KMT2A BAIAP2 PEAK1 ZCCHC7 MARK2 ARHGAP21 | 2.32e-04 | 720 | 130 | 14 | int:LYN |
| Interaction | HNF1B interactions | 2.36e-04 | 190 | 130 | 7 | int:HNF1B | |
| Interaction | GSC interactions | 2.50e-04 | 87 | 130 | 5 | int:GSC | |
| Interaction | MSR1 interactions | 2.76e-04 | 20 | 130 | 3 | int:MSR1 | |
| Interaction | PPP2R3C interactions | 3.03e-04 | 50 | 130 | 4 | int:PPP2R3C | |
| Interaction | PHLPP1 interactions | 3.15e-04 | 333 | 130 | 9 | int:PHLPP1 | |
| Interaction | PIBF1 interactions | 3.22e-04 | 200 | 130 | 7 | int:PIBF1 | |
| Interaction | FOXI1 interactions | 3.25e-04 | 92 | 130 | 5 | int:FOXI1 | |
| Interaction | RGPD4 interactions | 3.69e-04 | 22 | 130 | 3 | int:RGPD4 | |
| Interaction | DCTN1 interactions | MAP7D3 MAP1A CEP350 ZC2HC1A CEP131 MARK2 MAPRE2 USP15 ARHGAP21 DYNC1LI2 NIN | 3.82e-04 | 497 | 130 | 11 | int:DCTN1 |
| Interaction | PHF21A interactions | 3.91e-04 | 343 | 130 | 9 | int:PHF21A | |
| Interaction | CEBPA interactions | TRERF1 SPAST ZMYND8 E2F4 ZNF217 POGZ MED1 ZYX ZNF503 CCNT2 PRAM1 NCOR2 GTF2F1 MKI67 KMT2A FIP1L1 ACIN1 ASXL2 KNL1 | 3.98e-04 | 1245 | 130 | 19 | int:CEBPA |
| Interaction | NUP62 interactions | 4.00e-04 | 273 | 130 | 8 | int:NUP62 | |
| Interaction | VAV3 interactions | 4.37e-04 | 55 | 130 | 4 | int:VAV3 | |
| Interaction | FXR1 interactions | FOXM1 TRAF3 NANOG E2F4 TACC2 CRMP1 GRIP1 PRAM1 NCOR2 EPS15L1 ANKRD17 BAIAP2 MTUS2 | 4.53e-04 | 679 | 130 | 13 | int:FXR1 |
| Interaction | RNF43 interactions | MAP7D3 ANK3 C6orf132 MKI67 FIP1L1 NUP188 USP54 PEAK1 USP15 ARHGAP21 | 4.56e-04 | 427 | 130 | 10 | int:RNF43 |
| Interaction | TNRC6A interactions | 4.73e-04 | 280 | 130 | 8 | int:TNRC6A | |
| Interaction | GSK3B interactions | FOXM1 SYNRG MAP7D3 MAP1A CEP43 CEP350 PPARGC1A SNCAIP MKI67 MYOCD CEP131 PEAK1 MARK2 ARHGAP21 NIN | 4.83e-04 | 868 | 130 | 15 | int:GSK3B |
| Interaction | PLK4 interactions | 4.94e-04 | 154 | 130 | 6 | int:PLK4 | |
| Interaction | TRIM27 interactions | FAM184A NANOG FBF1 DCX PRAM1 GTF2F1 HROB PIK3C2B ZFHX3 IKBKB USP15 | 5.06e-04 | 514 | 130 | 11 | int:TRIM27 |
| Interaction | PCM1 interactions | FAM184A MAP7D3 FBF1 E2F4 CEP43 CEP350 TTLL4 CEP131 BAIAP2 NIN | 5.18e-04 | 434 | 130 | 10 | int:PCM1 |
| Interaction | RET interactions | 5.19e-04 | 284 | 130 | 8 | int:RET | |
| Interaction | SOX6 interactions | 5.47e-04 | 157 | 130 | 6 | int:SOX6 | |
| Interaction | H2BC21 interactions | TICRR RPS6KA5 PCLO HMGXB4 ZMYND8 POGZ PPARGC1A KDM4D TET1 MKI67 KMT2A CRYBG1 USP15 | 5.71e-04 | 696 | 130 | 13 | int:H2BC21 |
| Interaction | LATS2 interactions | 5.83e-04 | 289 | 130 | 8 | int:LATS2 | |
| Interaction | SASS6 interactions | 5.85e-04 | 159 | 130 | 6 | int:SASS6 | |
| Interaction | SYNE3 interactions | SYNRG FBF1 NUP214 CEP43 CEP350 NCOR2 CEP131 USP54 ARHGAP21 NIN | 6.17e-04 | 444 | 130 | 10 | int:SYNE3 |
| Interaction | HCFC1 interactions | 6.37e-04 | 293 | 130 | 8 | int:HCFC1 | |
| Interaction | CCNT1 interactions | 6.51e-04 | 225 | 130 | 7 | int:CCNT1 | |
| Interaction | RGPD2 interactions | 6.85e-04 | 27 | 130 | 3 | int:RGPD2 | |
| Interaction | CEP128 interactions | 6.96e-04 | 297 | 130 | 8 | int:CEP128 | |
| Interaction | SMC5 interactions | SALL3 MAP7D3 HMGXB4 ZMYND8 NUP214 POGZ MED1 PRAM1 NCOR2 EPS15L1 MKI67 KMT2A FIP1L1 ACIN1 ZCCHC7 KNL1 | 7.17e-04 | 1000 | 130 | 16 | int:SMC5 |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 5.55e-05 | 15 | 92 | 3 | 26 | |
| GeneFamily | PDZ domain containing | 1.26e-04 | 152 | 92 | 6 | 1220 | |
| GeneFamily | Cyclins | 3.81e-04 | 28 | 92 | 3 | 473 | |
| GeneFamily | Forkhead boxes | 1.36e-03 | 43 | 92 | 3 | 508 | |
| GeneFamily | Zinc fingers CXXC-type | 1.64e-03 | 12 | 92 | 2 | 136 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.48e-03 | 53 | 92 | 3 | 532 | |
| GeneFamily | LIM domain containing | 3.37e-03 | 59 | 92 | 3 | 1218 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.04e-03 | 206 | 92 | 5 | 682 | |
| GeneFamily | CD molecules|Mucins | 5.05e-03 | 21 | 92 | 2 | 648 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | FAM184A SPAST ANK3 RAPH1 PCLO ZMYND8 MUC19 POU2F2 FOXN3 PLEKHA6 DCX CRMP1 GRIP1 CREBRF PPARGC1A AJAP1 ZFHX3 RIMS1 BSN MAPRE2 MTUS2 | 1.23e-07 | 1106 | 130 | 21 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | FAM184A ANK3 POU2F2 TACC2 PLEKHA6 DCX CRMP1 ZC2HC1A AJAP1 ZFHX3 RIMS1 BSN MAPRE2 MTUS2 | 2.79e-07 | 513 | 130 | 14 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | ANK3 MUC19 POU2F2 PLEKHA6 DCX CRMP1 GRIP1 AJAP1 ZFHX3 RIMS1 BSN MTUS2 | 3.67e-06 | 465 | 130 | 12 | M39066 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | ANK3 MUC19 POU2F2 PLEKHA6 DCX CRMP1 GRIP1 ZC2HC1A AJAP1 ZFHX3 RIMS1 MTUS2 | 8.63e-06 | 506 | 130 | 12 | M39067 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.98e-05 | 166 | 130 | 7 | M6826 | |
| Coexpression | GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN | 2.58e-05 | 173 | 130 | 7 | M6923 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 SYNRG MAP7D3 RPS6KA5 PPP1R12A POU2F2 RCSD1 ZNF217 MED1 ZYX CEP350 CREBRF CCNT2 KMT2A CRYBG1 ASXL2 MAPRE2 USP15 CCNI NIN | 4.64e-05 | 1492 | 130 | 20 | M40023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 4.64e-05 | 335 | 130 | 9 | M39065 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | SPAST ANK3 PCLO MUC19 POU2F2 PLEKHA6 DCX CRMP1 PPARGC1A AJAP1 ZFHX3 BSN MAPRE2 | 4.90e-05 | 703 | 130 | 13 | M39070 |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 6.29e-05 | 199 | 130 | 7 | M9031 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 6.29e-05 | 199 | 130 | 7 | M4444 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 6.49e-05 | 200 | 130 | 7 | M3580 | |
| Coexpression | GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP | 6.49e-05 | 200 | 130 | 7 | M7207 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 6.49e-05 | 200 | 130 | 7 | M7841 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP | 6.49e-05 | 200 | 130 | 7 | M5711 | |
| Coexpression | SUZUKI_RESPONSE_TO_TSA | 9.21e-05 | 18 | 130 | 3 | M1680 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | 1.16e-04 | 295 | 130 | 8 | M39063 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.30e-04 | 300 | 130 | 8 | M8702 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 1.37e-04 | 99 | 130 | 5 | M768 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 1.43e-04 | 227 | 130 | 7 | M11234 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | 1.66e-04 | 488 | 130 | 10 | M39104 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | FAM184A ANK3 RAPH1 PPP1R12A ATP10B NUP214 C6orf132 CEP350 CCNT2 PPARGC1A ZC2HC1A HOXD1 CRYBG1 ROS1 ASXL2 ZCCHC7 | 2.10e-05 | 774 | 130 | 16 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | FAM184A TRAF3 SALL3 MAP7D3 MAP1A PCLO DCX CRMP1 ZNF503 GRIP1 PPARGC1A AJAP1 PIK3C2B MKI67 IKBKB USP15 ARHGAP21 KNL1 | 3.37e-05 | 989 | 130 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ANK3 PPP1R12A GAS2 NUP214 GATA5 DCX CRMP1 CEP350 PPARGC1A RGL1 FOXP4 SNCAIP HOXD1 MYOCD ASXL2 TBX5 | 3.43e-05 | 806 | 130 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-09 | 187 | 131 | 9 | 4d12c70c8ed922fbc8f7b139145611203735cab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-09 | 187 | 131 | 9 | e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-09 | 187 | 131 | 9 | e851ee46a6b4068a7bd7602ee183c0ace50ee4dd | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.69e-08 | 190 | 131 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.01e-07 | 191 | 131 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.09e-07 | 193 | 131 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-07 | 193 | 131 | 8 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.14e-07 | 194 | 131 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.18e-07 | 195 | 131 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-07 | 199 | 131 | 8 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-07 | 200 | 131 | 8 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-07 | 200 | 131 | 8 | fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 4.28e-07 | 157 | 131 | 7 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-07 | 167 | 131 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-07 | 171 | 131 | 7 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-07 | 173 | 131 | 7 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-06 | 179 | 131 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 186 | 131 | 7 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 187 | 131 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-06 | 188 | 131 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-06 | 188 | 131 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-06 | 188 | 131 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-06 | 188 | 131 | 7 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 189 | 131 | 7 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 189 | 131 | 7 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.49e-06 | 189 | 131 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 190 | 131 | 7 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.71e-06 | 193 | 131 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.77e-06 | 194 | 131 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-06 | 195 | 131 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.02e-06 | 198 | 131 | 7 | 076c862f2a723f0361749377561cae902068b1a0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-06 | 199 | 131 | 7 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-06 | 200 | 131 | 7 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-06 | 200 | 131 | 7 | 60b86c4a4e247b2673d31b085b440a6e574393bb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-06 | 200 | 131 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.41e-06 | 130 | 131 | 6 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 144 | 131 | 6 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 4.90e-06 | 147 | 131 | 6 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 165 | 131 | 6 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 167 | 131 | 6 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 167 | 131 | 6 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 167 | 131 | 6 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.05e-05 | 168 | 131 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.05e-05 | 168 | 131 | 6 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 171 | 131 | 6 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-05 | 171 | 131 | 6 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 172 | 131 | 6 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 173 | 131 | 6 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 174 | 131 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 175 | 131 | 6 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 176 | 131 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 178 | 131 | 6 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 180 | 131 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 181 | 131 | 6 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.61e-05 | 181 | 131 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 183 | 131 | 6 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.76e-05 | 184 | 131 | 6 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.76e-05 | 184 | 131 | 6 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 1.82e-05 | 185 | 131 | 6 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.82e-05 | 185 | 131 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 185 | 131 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.82e-05 | 185 | 131 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.82e-05 | 185 | 131 | 6 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-05 | 186 | 131 | 6 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.88e-05 | 186 | 131 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 187 | 131 | 6 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 187 | 131 | 6 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 187 | 131 | 6 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 187 | 131 | 6 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 187 | 131 | 6 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | lymphoid-B_cell|World / Lineage, cell class and subclass | 1.93e-05 | 187 | 131 | 6 | 2abbc01fd7f5b4e52113699625287893c991f8da | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.99e-05 | 188 | 131 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 188 | 131 | 6 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 188 | 131 | 6 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 188 | 131 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.99e-05 | 188 | 131 | 6 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.99e-05 | 188 | 131 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 188 | 131 | 6 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 188 | 131 | 6 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.99e-05 | 188 | 131 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.05e-05 | 189 | 131 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-05 | 190 | 131 | 6 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.11e-05 | 190 | 131 | 6 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.11e-05 | 190 | 131 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.11e-05 | 190 | 131 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 2.18e-05 | 191 | 131 | 6 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.18e-05 | 191 | 131 | 6 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 191 | 131 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.24e-05 | 192 | 131 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.24e-05 | 192 | 131 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 192 | 131 | 6 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|COVID-19 / Condition, Lineage and Cell class | 2.31e-05 | 193 | 131 | 6 | bffd97a73365e1dd23ff3b0320b4860f04ec091a | |
| Computational | Neighborhood of MAP4K4 | 5.19e-05 | 172 | 83 | 8 | GCM_MAP4K4 | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.33e-07 | 200 | 130 | 10 | 6032_UP | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.94e-06 | 196 | 130 | 9 | 3315_UP | |
| Drug | NSC-364372 | SPAST NUP214 ZYX CSRP3 EPN2 EPS15L1 LIMK2 HSH2D CEP131 IKBKB MAPRE2 USP15 NIN | 4.21e-06 | 484 | 130 | 13 | CID000435143 |
| Drug | SAHA; Up 200; 10uM; MCF7; HT_HG-U133A | 9.34e-06 | 180 | 130 | 8 | 6939_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.34e-06 | 180 | 130 | 8 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.10e-05 | 184 | 130 | 8 | 2321_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 1.14e-05 | 185 | 130 | 8 | 1114_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.55e-05 | 193 | 130 | 8 | 5273_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.61e-05 | 194 | 130 | 8 | 3854_UP | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 3082_UP | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 3383_UP | |
| Drug | dimethyloxalylglycine; Down 200; 1000uM; PC3; HG-U133A | 1.73e-05 | 196 | 130 | 8 | 584_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 4409_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.86e-05 | 198 | 130 | 8 | 1004_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 3713_UP | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 6217_UP | |
| Drug | bromfenacoum | SYNRG ANK3 RAPH1 PPP1R12A ZYX EPN2 GTF2F1 ZC2HC1A FIP1L1 BAIAP2 BSN NOS1 ARHGAP21 MTUS2 | 1.95e-05 | 644 | 130 | 14 | ctd:C013418 |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.47e-05 | 178 | 130 | 7 | 3998_DN | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 8.01e-05 | 180 | 130 | 7 | 6579_UP | |
| Drug | scriptaid; Up 200; 10uM; MCF7; HT_HG-U133A | 9.19e-05 | 184 | 130 | 7 | 6901_UP | |
| Drug | 5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione | 9.67e-05 | 3 | 130 | 2 | ctd:C570539 | |
| Drug | Alsterpaullone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.02e-04 | 187 | 130 | 7 | 7051_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A | 1.24e-04 | 193 | 130 | 7 | 1961_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 4245_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 4410_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 3807_DN | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 4529_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | 1.32e-04 | 195 | 130 | 7 | 1366_DN | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 3366_UP | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 4418_DN | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 4424_UP | |
| Drug | ST021200; Up 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 7554_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.36e-04 | 196 | 130 | 7 | 2035_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 6042_UP | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 6435_UP | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 5072_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 6732_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 2068_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 2054_DN | |
| Drug | (+/-)-verapamil hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.45e-04 | 198 | 130 | 7 | 161_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.45e-04 | 198 | 130 | 7 | 421_DN | |
| Drug | topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 1.45e-04 | 198 | 130 | 7 | 915_UP | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; HL60; HG-U133A | 1.45e-04 | 198 | 130 | 7 | 1430_UP | |
| Drug | wortmannin; Up 200; 0.01uM; HL60; HG-U133A | 1.50e-04 | 199 | 130 | 7 | 389_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A | 1.50e-04 | 199 | 130 | 7 | 1964_UP | |
| Drug | exemestane; Up 200; 0.01uM; MCF7; HG-U133A | 1.50e-04 | 199 | 130 | 7 | 165_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 7226_UP | |
| Drug | AH6809; Down 200; 1uM; PC3; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 7075_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 4691_UP | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.54e-04 | 200 | 130 | 7 | 1492_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; HL60; HG-U133A | 1.54e-04 | 200 | 130 | 7 | 1994_DN | |
| Disease | prostate carcinoma | GDF5 TCF4 SALL3 POU2F2 ZNF217 GATA5 SOX13 CRMP1 FARP2 CEP350 FOXP4 PIK3C2B ZFHX3 MYOCD BSN KNL1 PHLPP2 TBX5 | 4.82e-08 | 891 | 126 | 18 | EFO_0001663 |
| Disease | metabolite measurement, body weight gain | 1.63e-05 | 12 | 126 | 3 | EFO_0004566, EFO_0004725 | |
| Disease | Neurodevelopmental Disorders | 5.04e-05 | 93 | 126 | 5 | C1535926 | |
| Disease | unipolar depression, bipolar disorder | 5.79e-05 | 156 | 126 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | electrocardiography | FAM184A FOXN3 PLEKHA6 LRCH1 PPARGC1A MYOCD ROS1 BAIAP2 MAPRE2 TBX5 | 9.63e-05 | 530 | 126 | 10 | EFO_0004327 |
| Disease | QT interval | DTL PP2D1 LRCH1 PPARGC1A AJAP1 ALPK3 ZFHX3 ROS1 ARHGAP21 TBX5 | 1.02e-04 | 534 | 126 | 10 | EFO_0004682 |
| Disease | Partial Fetal Alcohol Syndrome | 1.79e-04 | 5 | 126 | 2 | C3661483 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 1.79e-04 | 5 | 126 | 2 | C0814154 | |
| Disease | Alcohol Related Birth Defect | 2.68e-04 | 6 | 126 | 2 | C3146244 | |
| Disease | Ischemic stroke | 4.99e-04 | 324 | 126 | 7 | HP_0002140 | |
| Disease | major depressive disorder | 5.49e-04 | 155 | 126 | 5 | MONDO_0002009 | |
| Disease | diastolic blood pressure, systolic blood pressure | TRAF3 ANK3 GATA5 LRCH1 CEP350 PPARGC1A RGL1 FIP1L1 ZFHX3 MYOCD | 6.20e-04 | 670 | 126 | 10 | EFO_0006335, EFO_0006336 |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.90e-04 | 447 | 126 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Malignant neoplasm of breast | FOXM1 TRERF1 SPAST RAPH1 TACC2 NUP214 RGL1 FOXP4 MKI67 SLC39A6 USP54 IKBKB ZNF541 | 7.00e-04 | 1074 | 126 | 13 | C0006142 |
| Disease | Malignant neoplasm of salivary gland | 9.46e-04 | 45 | 126 | 3 | C0220636 | |
| Disease | colon cancer (implicated_via_orthology) | 9.70e-04 | 11 | 126 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Salivary Gland Neoplasms | 1.07e-03 | 47 | 126 | 3 | C0036095 | |
| Disease | Mitral valve prolapse, response to surgery | 1.16e-03 | 12 | 126 | 2 | EFO_0009951, HP_0001634 | |
| Disease | brain disease (is_implicated_in) | 1.16e-03 | 12 | 126 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.37e-03 | 13 | 126 | 2 | C2985290 | |
| Disease | retinal vasculature measurement | 1.74e-03 | 517 | 126 | 8 | EFO_0010554 | |
| Disease | body weights and measures, body height | 1.83e-03 | 15 | 126 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | Autosomal recessive primary microcephaly | 1.83e-03 | 15 | 126 | 2 | cv:C3711387 | |
| Disease | developmental dysplasia of the hip | 2.09e-03 | 16 | 126 | 2 | EFO_1000648 | |
| Disease | reaction time measurement | 2.11e-03 | 658 | 126 | 9 | EFO_0008393 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.18e-03 | 60 | 126 | 3 | C4722327 | |
| Disease | Fetal Alcohol Syndrome | 2.36e-03 | 17 | 126 | 2 | C0015923 | |
| Disease | depressive symptom measurement | 2.41e-03 | 426 | 126 | 7 | EFO_0007006 | |
| Disease | alcohol consumption measurement | TCF4 RAPH1 RPS6KA5 PCLO POU2F2 MED1 GRIP1 NCOR2 ZFHX3 ASXL2 PEAK1 MAPRE2 PHLPP2 | 2.56e-03 | 1242 | 126 | 13 | EFO_0007878 |
| Disease | sexual dimorphism measurement | FOXM1 GDF5 LINC02875 FARP2 PRAM1 NCOR2 HROB ZNF335 ALPK3 ZFHX3 ASXL2 BSN | 2.80e-03 | 1106 | 126 | 12 | EFO_0021796 |
| Disease | wellbeing measurement | 2.95e-03 | 692 | 126 | 9 | EFO_0007869 | |
| Disease | Brugada syndrome | 2.95e-03 | 19 | 126 | 2 | MONDO_0015263 | |
| Disease | Prostate cancer, familial | 3.24e-03 | 69 | 126 | 3 | C2931456 | |
| Disease | Nonorganic psychosis | 3.24e-03 | 69 | 126 | 3 | C0349204 | |
| Disease | eosinophil percentage of granulocytes | 3.37e-03 | 234 | 126 | 5 | EFO_0007996 | |
| Disease | stroke | 3.44e-03 | 144 | 126 | 4 | EFO_0000712 | |
| Disease | haptoglobin measurement | 3.60e-03 | 21 | 126 | 2 | EFO_0004640 | |
| Disease | activities of daily living score measurement | 3.60e-03 | 21 | 126 | 2 | EFO_0008451 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 3.70e-03 | 147 | 126 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | otitis media (implicated_via_orthology) | 3.95e-03 | 22 | 126 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | nasopharyngeal neoplasm | 4.07e-03 | 151 | 126 | 4 | EFO_0004252 | |
| Disease | hematocrit | RAPH1 GATA5 PLEKHA6 PPARGC1A NCOR2 CBY1 ANKRD17 ASXL2 BSN ARHGAP21 TBX5 | 4.10e-03 | 1011 | 126 | 11 | EFO_0004348 |
| Disease | Parkinson's disease (is_implicated_in) | 4.26e-03 | 76 | 126 | 3 | DOID:14330 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSQGLKEKSKSPSPP | 376 | Q9UKV3 | |
| PPSSTSSHKSFPKIF | 126 | Q7L0X2 | |
| SGKDPFVPSSAAKPS | 836 | Q9UBC2 | |
| PTNPSFQKPSTSAFP | 296 | O60583 | |
| NPLPSSFPGKKITSR | 166 | Q8IUR6 | |
| SPASSSPKPGSKAGS | 321 | Q9UK96 | |
| PQGTRKSAPSSKATP | 1866 | Q96L96 | |
| KSAPSSKATPQASEP | 1871 | Q96L96 | |
| GLAKPPAAAKSSPSL | 116 | Q9UKB5 | |
| NTFSPKKTPPRKSAS | 6 | Q9Y3M2 | |
| ISNTFKPSSPGKKPG | 226 | A7E2U8 | |
| PSSVPGPDFSKDNSK | 281 | Q14094 | |
| VLPSKSKAPGSPLSS | 206 | Q6JBY9 | |
| PSNTPTFSIKTSPAK | 461 | Q9NZJ0 | |
| TKSGPSPLSSPNGKL | 1691 | O75179 | |
| LQTSSPYKQAGPSPK | 1231 | A7MBM2 | |
| PKGPKTFLSPAQSEA | 1106 | Q8NB25 | |
| PSKNIPNPSASSKTD | 861 | Q76L83 | |
| DFSASTPKSSNPPKR | 1376 | O94823 | |
| PAPKSTSTPAGTKKD | 926 | Q5JR59 | |
| KATPFSSPGTATALP | 3766 | Q9HC84 | |
| VSKFTPPAESGSPSK | 1001 | Q70E73 | |
| KHSTPSPTKYSLSPS | 776 | Q99666 | |
| SPTPTKEQPKSTASG | 531 | Q9NZL6 | |
| KHSTPSPTKYSLSPS | 776 | O14715 | |
| SKSPGNTSQPPAFFS | 2256 | Q9Y618 | |
| PSSRKAKSPAPGLAS | 2406 | Q9Y618 | |
| GKAPPKAGSVPSSFL | 131 | P43026 | |
| SSFSKSPESLPGPAL | 1321 | P78559 | |
| PSTASNSLPEPAKKS | 691 | O14920 | |
| LSGTTPTKFIKNPGS | 306 | Q9GZZ0 | |
| RSNSISKSPGPSSPK | 286 | P53671 | |
| KPSSARKTPESFLGP | 501 | O95208 | |
| FSPPVSSGKNGPTSL | 26 | P15884 | |
| SKLSQPQSKSSFPLP | 166 | Q9NYS0 | |
| GPLPAKASPLSTKAS | 566 | Q9UPA5 | |
| STKASPLPSKASPQA | 576 | Q9UPA5 | |
| ASVPSSSPGTSVKKP | 401 | O43237 | |
| KTDSAKPSQSFPPTG | 796 | Q9Y6V0 | |
| TAKTSFTGSSPPGKL | 1851 | Q7Z5P9 | |
| GPVNSPKTKSSSSTP | 491 | Q9H792 | |
| PSTKAEFTSPPSLFK | 251 | Q6UN15 | |
| PDSSTSPKGKQPTSA | 66 | Q9H9S0 | |
| PFSVSPTGPSTKIKA | 51 | P09086 | |
| SKKPSSTPSSTPGPS | 426 | Q6B0I6 | |
| SPTTNSTAPFGLKPR | 536 | Q9Y2L9 | |
| GPSTFSFVPPSKASL | 516 | P35658 | |
| PFSSASKPAASGPLS | 611 | P35658 | |
| FSTDQPPLPKKGQSS | 1471 | Q8NG31 | |
| SFLKPSQPFPKDSGS | 581 | Q8N3J3 | |
| SQPLNPVPGSSSFSK | 381 | Q8IVH2 | |
| HGKTTPTKTLQPSNP | 771 | O75582 | |
| SFTSAPKQTPDSGKP | 2941 | P46013 | |
| KTTPSPTDKAAGASP | 586 | Q8TE49 | |
| SSVGVLSPQKKSPPT | 491 | Q9UGU5 | |
| ATSLKSPSQPQAPKD | 271 | Q96JZ2 | |
| VGPKFSIPSPTFSKS | 696 | Q8IZQ8 | |
| PTSGKQSPTKNGSPS | 286 | P29475 | |
| LPPRKGSPSSSKISQ | 171 | O00750 | |
| RSLTQKPGSKSTPAP | 1561 | Q86UR5 | |
| PPSKKPRYSESSGTQ | 326 | Q9UBK2 | |
| SRSKPSPGICTSKPS | 266 | B2RXH4 | |
| PPAGFTKTPKSSSPA | 426 | Q5T0Z8 | |
| TSKAKPSLASPVCPG | 326 | Q9BWX5 | |
| AIPTKKSLPSPSSSG | 121 | Q8TES7 | |
| SSGPNPSTSFEPIKA | 326 | Q16254 | |
| AKKASETSPFPPAKS | 241 | Q96C57 | |
| SPPKSPEGKTSAQTT | 156 | O95684 | |
| TSGFSPAPKLVESPK | 326 | Q96S94 | |
| PPSKKPESSGISVSS | 6 | O00409 | |
| KDPKSSPASSPSFAV | 26 | Q86X59 | |
| TAGPKASPTPQKTSA | 281 | O43602 | |
| DKGRSQKTPTSPLSP | 1246 | Q5VT06 | |
| KTPSAPQSAESTGPK | 2136 | Q12955 | |
| AKSSPAAKPGSTPSR | 206 | Q15555 | |
| AAKPGSTPSRPSSAK | 211 | Q15555 | |
| KASSTAKVPASPLPG | 446 | Q7KZI7 | |
| PSAILNGTGSPTKFK | 761 | Q8IWC1 | |
| SQSPTPRPKKSYSGL | 506 | Q08050 | |
| NKKLAPSSTPSNIAP | 3231 | Q03164 | |
| ASTKGPSVFPLAPSS | 1 | P01857 | |
| PSVFPLAPSSKSTSG | 6 | P01857 | |
| GQKPPSRPSSSASKK | 316 | P35212 | |
| ASAASPESKPSPGTK | 71 | Q9Y4K1 | |
| PKPARSVTTSNPSKF | 96 | P50461 | |
| SPYTKSASQTKPPDG | 21 | Q9Y3R0 | |
| GLSTKSPQPSPSSRK | 471 | O94887 | |
| SLSGSPKPFSPQLSA | 486 | Q9ULU4 | |
| SPAPSNGESFRSKSP | 906 | Q9BXA9 | |
| PSGKKRPASLSTAPS | 106 | Q9UPN4 | |
| KYATPAPSAKSSPSK | 511 | Q14194 | |
| PPSSKAKSPISSGSG | 1216 | Q15648 | |
| SPASKSKKRPLFGSP | 691 | A1L443 | |
| SPASKSKKRPLFGSP | 676 | Q5VZR2 | |
| APSPSPSPSSKSSGK | 181 | O43903 | |
| SLSGKSTPQPPSGKT | 431 | P35269 | |
| SGPQKSSSPFTPLQK | 266 | Q68CQ4 | |
| KDSSPSSSPSPKGFR | 336 | Q6WKZ4 | |
| TKDKTFPPSFPSGTI | 586 | Q9UMZ2 | |
| SKPESALGAPSKSPS | 26 | Q99593 | |
| LFKNGKSLTPSASTP | 246 | Q8N4C6 | |
| HSTPSPTKYSLSPSK | 776 | P0DJD1 | |
| PDSSTSPKGKQPTSA | 66 | Q6NSW7 | |
| PPSFPTNKAATVKSA | 876 | Q7Z3K3 | |
| SSAFPKKASQPPLSD | 266 | Q96QH2 | |
| KSEGKSLPSSPSSPS | 551 | Q9Y6H5 | |
| GTPKTNRTNKPSTPT | 291 | Q9UBP0 | |
| GKLFPKDVSSSTPPS | 211 | Q13433 | |
| SPKTASATPAPLKND | 1851 | Q8NFU7 | |
| PKSLSPPQSQSKLSD | 321 | Q9UQB8 | |
| SLPTASASKFPSSGP | 351 | Q9Y679 | |
| PFSLVSGSQGSPTKP | 706 | Q9Y2H5 | |
| TAKPKAPELPNTSSS | 296 | Q9UN79 | |
| AFKPDPNSSSFKKPT | 511 | Q13114 | |
| PQSTFKPKAEVPSSS | 81 | P0CJ78 | |
| GNSTVTSSPPVTPKK | 1296 | Q7Z2Z1 | |
| IKDAPKPATPSSSSG | 1061 | Q6ZVD8 | |
| TFSKAAPSVPSKPSD | 331 | Q9UBZ9 | |
| FQSPASKSPKGAAPD | 131 | Q9H6E5 | |
| TPKSPGASNFSTLPK | 226 | Q9Y4E8 | |
| PSPQGKSTSLSKASP | 1716 | Q5SRE5 | |
| TSLKPLPGNFSFTPK | 931 | P08922 | |
| KTPSSPSKSPASFEI | 2386 | O95359 | |
| PPALKKSNSPGTASS | 171 | Q96GY0 | |
| SQIGKPDPSPSSKLS | 121 | Q96F45 | |
| KNSSPEPQALTPSSK | 711 | P98168 | |
| TTLPTSTGFPKPNSQ | 176 | Q6NX49 | |
| SSPGSFKTQKPSKPF | 481 | Q8N3Z6 | |
| PVATPFSSKSSTKPA | 176 | Q15942 | |
| PKSAFPAQSKSLPSA | 776 | O75362 | |
| GLSPYPQKPSSSKDS | 1141 | Q14679 | |
| KSPSLSGASAKPAPQ | 681 | Q5T5U3 | |
| PSPPSAATAASKKFS | 1006 | Q9H4Z2 | |
| SSAGPPADPSKSKLT | 781 | Q9H0D2 | |
| ISSSCGAPSPTKPKT | 786 | Q15911 | |
| GFTPSNTALTSPKPN | 3136 | Q15911 | |
| KNSSPSDSKPPFSQG | 1161 | Q70EL1 | |
| PNKSPSKGPLLFSTS | 486 | A8MPX8 | |
| KLLPPKPSSQGFTNS | 591 | Q96PN7 | |
| SSGQATPTSPIKKFP | 401 | O14974 |